| Courtney Shelton, LCSW | |
|
366 Medallion Dr, Prince Frederick, MD 20678-4467 | |
| (410) 474-4863 | |
| Not Available |
| Full Name | Courtney Shelton |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 366 Medallion Dr, Prince Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063291300 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CSW.09928853 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Courtney Shelton, LCSW 366 Medallion Dr, Prince Frederick, MD 20678-4467 Ph: (410) 474-4863 | Courtney Shelton, LCSW 366 Medallion Dr, Prince Frederick, MD 20678-4467 Ph: (410) 474-4863 |
News Archive
A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a study led by The University of Texas MD Anderson Cancer Center.
Researchers from the Cedars-Sinai Heart Institute and the Cedars-Sinai Department of Medicine are expanding their ongoing evaluation of a novel cell-based therapeutic candidate into the area of pulmonary arterial hypertension (PAH).
The American Medical Group Association announced today that it will present the AMGA Distinguished Corporate Partner Award on March 15 to Exact Sciences at its 2012 Annual Conference, March 14-16 at the Hilton Bonnet Creek Resort in Orlando.
Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have conducted a study which has found striking brain similarities in bipolar disorder and schizophrenia. The research has also pinpointed for the first time that a process which controls how information is transmitted from neuron to neuron in the brain is altered in both conditions and may potentially contribute to the developments of improved treatments in the future.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
› Verified 5 days ago
Ms. Tamera Ireland Olson, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 995 Prince Frederick Blvd, Ste. 209, Prince Frederick, MD 20678 Phone: 410-610-6602 Fax: 410-535-2226 | |
Ms. Sharman Warrick, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 65 Duke St # 661, Suite 207, Prince Frederick, MD 20678 Phone: 410-535-4854 Fax: 410-414-8002 | |
Amanda Lynn Schiavoni, LCSW C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 301 Steeple Chase Drive, Suite 104, Prince Frederick, MD 20678 Phone: 410-535-4854 Fax: 410-535-6272 | |
Amanda Kurtz, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 975 Solomons Island Rd N, Prince Frederick, MD 20678 Phone: 410-535-5400 | |
Todd Gerard Kruder, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 975 Solomons Island Rd N, Prince Frederick, MD 20678 Phone: 410-535-5400 Fax: 410-414-9413 | |
Mrs. Holly Rogers Briscoe, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 65 Duke Street, Suite 206, Prince Frederick, MD 20678 Phone: 410-535-5425 Fax: 410-535-5489 |